Showing results (111-120 of 186) with videos related to

Sort By:
Pageof 19
Journal of Human Hypertension|July 21, 2001
A forced titration study of antihypertensive efficacy of candesartan cilexetil in comparison to losartan: CLAIM Study IID G Vidt, W B White, E Ridley, et al.
Forensic Science International|February 9, 1996
Comprehensive drug screening in blood for detecting abused drugs or drugs potentially hazardous for traffic safetyP Lillsunde, L Michelson, T Forsstrom, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|June 21, 2001
Antihypertensive efficacy of candesartan in comparison to losartan: the CLAIM studyG Bakris, A Gradman, M Reif, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|June 14, 2008
An evaluation of the effects of an angiotensin receptor blocker on health-related quality of life in patients with high-normal blood pressure (prehypertension) in the Trial of Preventing Hypertension (TROPHY)Setareh A Williams, Eric L Michelson, Valerie A Cain, et al.
The American Journal of Medicine|October 17, 1983
Treatment of severe hypertension with labetalol compared with methyldopa and furosemide. Results of a long-term, double-blind, multicenter trialJ D Wallin, D Wilson, N Winer, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|June 21, 2001
The Effects of Candesartan Cilexetil in Isolated Systolic Hypertension: A Clinical Experience TrialJoel M. Neutel, Matthew R. Weir, Marvin Moser, et al.
The American Journal of Cardiology|October 1, 1980
Echocardiographic features of atrioventricular and ventriculoatrial conductionM Naito, L S Dreifus, T J Mardelli, et al.
Pacing and Clinical Electrophysiology : PACE|March 1, 1986
Effects of AV sequential versus asynchronous AV pacing on pulmonary hemodynamicsL S Dreifus, H Mitamura, A Rhauda, et al.
Archives of Internal Medicine|August 13, 2008
The hemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and Morbidity (CHARM) programHertzel C Gerstein, Karl Swedberg, Jonas Carlsson, et al.
American Journal of Hypertension|November 1, 1989
A multicenter double-blind study of the efficacy and safety of once and twice daily dilevalol compared to propranololJ A Schoenberger, J D Wallin, J I Gorwit, et al.
Pageof 19